Reported May 17, 2023 · Ongoing
Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc.,…
Camber Pharmaceuticals Inc.
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Camber Pharmaceuticals Inc. · 800 Centennial Ave Ste 1 · Piscataway, NJ · 08854
Is this the product you have?
Atovaquone Oral Suspension USP750 mg/5 mLPackaged in 210 mL bottle
- Manufactured forCamber Pharmaceuticals, Inc., Piscataway, NJ 08854
- Manufactured byHetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC# 31722-629-21
- Lot codes and dates
Lot# E220182Exp. 12/31/2023
- Amount recalled
- 1568 bottles
Where it was sold
- Nationwide
Why it was recalled
Stop using this product now
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Camber Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.